Vevye offers a semiflourinated alkane formulation that targets dry eye inflammation by enhancing the penetration of ...
The FDA has again issued a CRL to Aldeyra regarding the New Drug Application for reproxalap for the treatment of dry eye disease.
The FDA has asked for another well-controlled trial to establish the efficacy of reproxalap in dry eye disease.
Five years from the start of the COVID-19 pandemic, numerous academic studies have shown how the novel coronavirus affects ...
Recent estimates show that there are over 2 billion users on Instagram, of which over 726.8 million interact with reels on ...
Aldeyra Therapeutics shares fell 73% to $1.42 in the regular session after it reported a Food and Drug Administration complete response letter for reproxalap for treatment of dry eye disease. The ...
The FDA issued a complete response letter for the resubmission of the reproxalap new drug application for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results